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Abstract 
Air pollution (indoor and outdoor air) is a major issue in public health as epidemiological studies 
haven pointed to the numerous detrimental health consequences (notably, respiratory 
and cardiovascular pathology). In the last fifteen years, air pollution has also been considered as a 
potent environmental risk factor for neurological diseases and neuropathology. In this review, the 
authors examine the impact of air pollution on children’s brain development and its clinical, 
cognitive, brain structural and metabolic consequences. Long-term potential consequences for 
adults’ brain and effects on multiple sclerosis are also discussed. One challenge is assessing lifetime
exposures to outdoor and indoor environments, including occupational exposures: how much, for 
how long and what type. The diffuse neuroinflammation, the damage to the neurovascular unit, and 
the production of auto-antibodies to neural and tight junction proteins are worrisome findings in 
children chronically exposed to concentrations above current standards for ozone and fine 
particulate matter (PM 2.5) and may constitute significant risk factors for the development of 
Alzheimer’s disease later in life. At last, we review data supporting the role of air pollution as risk 
factor in multiple sclerosis, pointing on the effect of Particulate Matter (PM 10) and nitrogenous 
oxides.
Résumé
La pollution de l’air (ambiant et atmosphérique) est un problème majeur de Santé Publique 
comme le montrent les études épidémiologiques illustrant les nombreuses conséquences 
sanitaires (notamment respiratoires et cardio-circulatoires). Au cours des quinze dernières années,
la pollution de l’air a été reconnue comme un  facteur de risque environnemental important dans 
les affections neurologiques. Dans cette revue les auteurs évaluent l’impact de la pollution de l’air 
sur le développement cérébral de l’enfant avec ses conséquences cliniques, cognitives, mais aussi 
structurales et métaboliques. Les conséquences potentielles à long terme sur le cerveau des 
adultes sont ensuite abordées. 
L’évaluation, vie entière, des expositions à des polluants ambiants et extérieurs constitue un réel 
défi : à quelle dose, pendant combien de temps, par quel type. Le constat, chez des enfants 
exposés de manière chronique à de l’Ozone et aux particules fines (PM2.5) à des concentrations 
au-delà des normes habituelles, d’une neuroinflammation diffuse, de lésions de l’unité 
neurovasculaire, de la production d’anticorps dirigés contre les protéines neuronales et des 
jonctions serrées, est particulièrement préoccupant. En effet, ces modifications pourraient être un
facteur de risque du développement ultérieur d’une maladie d’Alzheimer. Enfin, sont analysées 
des données qui permettent de considérer la pollution de l’air (et notamment les particules fines 
(PM 10) et les Oxydes d’azote) comme un nouveau facteur de risque de la sclérose en plaques. 
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1. Introduction 
Environmental Neurology (EN) is a new field of practice and research[1] dedicated to a global, 
comprehensive and translational study of the action of Environment on Man.  Albert Einstein 
defined environment as “everything but me”.  Environmental Medicine uses four approaches for 
the study of environmental factors affecting humans: approach by agents (e.g. chemicals), by 
milieu (e.g. a water, air), by population (e.g. children) and of course by pathologies. EN links 
neurology with public health issues. WHO define air pollution as a ”contamination of the indoor or
outdoor environment by any chemical, physical or biological agent that modifies the natural 
characteristics of the atmosphere” (http://www.who.int/topics/air_pollution/en/  ).
With the industrial revolution in the Eighty-century, the air pollution increased dramatically. 
Combustion of fossil energies (coal, coke, gasoline and diesel fuel), needed to power industries, 
transportations and housing, is responsible for the release for many hundreds of contaminants 
into the atmosphere. However the mixture of the air pollutants changed in the twenty-century; oil
and diesel replaced coal and became the major energy sources used in expending cities 
(urbanization) in the western countries. By the sixties and seventies two major types of mixtures 
were recognized the London-type smog (linked with fossil fuel combustion and PM emissions) and 
the Los Angeles-type smog or photochemical oxidant pollution whose main compounds are ozone 
and the secondary aerosols (sulfate and nitrate oxides)[2].
Nowadays, only some atmospheric air pollutants are monitored, depending on their health effects 
and regulations in the different countries, e.g. ozone, sulphur dioxide, carbon monoxide, nitrogen 
dioxide, lead and particulate matter (PM). The other air contaminants referred as hazardous 
pollutants should also be measured because highly neurotoxic chemicals are included e.g. volatile 
organic compounds (benzene, formaldehyde, tri- and tetrachloroethylene, toluene, polycyclic 
aromatic hydrocarbons PAHs etc.) and metals (lead, manganese, iron, mercury, arsenic, cadmium, 
cobalt, etc.)[3].
The neurological effects associated with sustained exposures to concentrations of outdoor
air pollutants above the current international air quality standards are an important issue for the
millions of people living in megacities around the world, including Mexico City Metropolitan Area
(MCMA), Tehran and Paris, for example.  Paris residents are exposed to high concentrations of
particulate matter (PM), nitrogen oxide (NOx), and PAHs and share with residents in New York,
Toronto,  Salt  Lake  City,  Fairbanks  AK,  Provo,  UT,  Los  Angeles-South  Coast  Air  Basin,  CA,
Nogales, AZ and MCMA their main sources of pollution: transport, industry and heating. Airborne
PM varies in its physical and chemical composition, source and particle size. PM including PM10,
coarse particles larger than 2.5 μm and smaller than 10 μm, PM2.5, fine particles larger than 100 nm
and smaller than 2.5 μm and ultrafine PM <100 nm) and their components, are key pollutants in
European cities.
This review will  focus on three topics,  the detrimental  impact of environmental  factors
upon the brain in development, its long-term potential neurodegenerative consequences and air
pollution as a risk factor in multiple sclerosis (MS). We will discuss how to evaluate air pollutant
exposures and concentration estimates, relevant publications, and the uncertainties and expected
long-term brain effects on urban residents. 
2. Assessing air pollutant exposures in our patients
The first issue we faced in evaluating patient’s exposures to air pollutants is: how much, for how 
long and what type? And since most people are exposed to complex mixtures of air pollutants from 
different sources-indoors and outdoors and occupational exposures-all available information has to 
be considered. Meteorological conditions, including precipitation, sunshine, ambient temperatures, 
etc., are included in the search for environmental factors associated with central nervous system 
(CNS) effects.  Traffic-related air pollutants are a prime exposure source in urbanites and we know 
the highest exposures are seen near busy roads. Automated geocoding methods are being used to 
estimate exposures and factors such as road edge and road centerline, road curvature, road width 
and the presence of ramps, can substantially alter exposure estimates near roads because of the 
spatial gradients of traffic-related pollutant concentrations[2]. Land-use regression models, line-
dispersion models, proximity-based assessments, personal monitors along with interquartile-range 
increases in air pollutant levels, inclusion of several lag day evaluations, peak seasonal associations 
are used to identify key air pollutants and exposure windows conferring the greatest risk.  The 
primary objectives of neurological endpoints and air pollution exposures will depend on the 
analysis of the neurological variables and if the effects we are interested relate to short or chronic 
air pollution exposures. Thus, a time-stratified case-crossover design will be suitable to investigate 
associations between acute exposures to PM and gaseous air pollutants and an acute event such as 
stroke, while evaluating the risk of Alzheimer’s development will require years of air pollution 
evaluations [3-5]. Moreover, since air pollution levels are generally believed to be higher in 
deprived areas, keeping in mind air pollution inequalities and ways of transportation at national, 
regional and city level have to be contemplated [6]. Platt et al., showed that elevated PM levels can 
be a consequence of 'asymmetric pollution' from two-stroke scooters, that although constitute a 
small fraction of the fleet, can dominate urban vehicular pollution through organic aerosol and 
aromatic emission factors up to thousands of times higher than from other vehicle classes [7]. 
Also important is the fact that air pollutant concentrations can have an impact upon a neurological 
endpoint without necessarily going over the accepted air quality standards. A good example is the 
association between low-level O3 exposure and ischaemic stroke in a high vascular risk subgroup 
demonstrated in a case-crossover study in Nice, France [8]. 
Evaluation of air pollutant exposures in private practice or in a hospital setting should include 
childhood exposures (including parents occupations), a full occupational and residential history, 
along with hobbies, transportation means, tobacco exposures (1st, 2nd and 3rd hand exposures), 
cooking habits, type of stove, heating sources, type of housing, distance to busy roads and highways
and fixed sources of air pollutants. In long-term studies, the ability to have good spatial exposure 
assessments and a proper control of confounders related to air pollution and the neurological 
endpoint, like socioeconomic status (SES) is key. 
3. Brain effects of polluted air on children.
Children’s prime health and optimal brain development require clean air. Brain effects associated 
with intra and extrauterine air pollution exposures in children are not broadly recognized. Pediatric 
health providers acknowledge the impact of intrauterine factors, parent-child interactions, and 
cognitive stimulation, maternal socioeconomic status during pregnancy, child’s nutrition and 
exposure to complex learning stimuli, all vital for brain development; unfortunately, air pollution 
brain effects rooted in intrauterine life and childhood are not generally acknowledged. A crucial 
point to remember is that overall children and adults are exposed to complex mixtures of air 
pollutants and although some correlations can be done with specific pollutants, it is extremely 
difficult to pin point specific CNS effects to specific environmental pollutants. 
31. Cognition effects and brain structural changes
Prenatal and postnatal exposures to complex mixtures of air pollutants produce adverse effects on 
neurodevelopment in early childhood, teen and young adulthood years. Cognition effects have been 
associated to a wide range of pollutants from tobacco, black carbon (a marker for traffic particles), 
wood smoke exposures in cooking practices, to common urban air pollutants across the world [9-
17].
Black carbon exposures and cognition were explored in 202 Boston, Massachusetts, children 9.7 
±1.7 years, in a prospective birth cohort study (1986-2001) [13]. Black carbon (per interquartile-
range increase) was associated with decreases in the vocabulary, matrices and composite 
intelligence quotient scores of the Kaufman Brief Intelligence Test and with decreases on the visual 
subscale and general index of the Wide Range Assessment of Memory and Learning. Higher levels 
of black carbon predicted decreased cognitive function across assessments of verbal and nonverbal 
intelligence and memory constructs.
Environmental tobacco smoke (ETS) exposure negatively impacts cognitive abilities among U.S. 
children and adolescents 6-16 years of age [12]. Significant inverse relationships between serum 
cotinine and scores on reading, math, and block design, but not digit span (Wechsler Intelligence 
Scale for Children-III) were observed in exposed children even at low levels of exposure. The 
combination of prolonged exposure to traffic-related air pollution (NO2, an indicator for traffic-
related air pollution) as well as noise also adversely affects digit memory span in 9-11 year olds 
living around the Schiphol-Amsterdam Airport [14]. Structural brain changes are seen in highly 
exposed urban clinically healthy children when compared to clean air controls. Fifty six percent of 
healthy Mexico City children versus controls showed prefrontal white matter hyperintensities 
(WMH) by magnetic resonance imaging (MRI) and similar lesions were observed in healthy young 
dogs (57%) living in an animal facility in the same neighborhood as the children’s [9]. 
Critical to this review, Mexico City dogs had WMH frontal lesions with vascular subcortical 
pathology associated with neuroinflammation, gliosis, and ultrafine particle deposition. The 
presence of WMH in urban children is important because childhood SES predicts the burden of 
brain WMH in older adults, establishing a potential link with dementia and stroke in later years 
[18]. The presence or absence of WMH is critical for early identification of children at risk in the 
clinical setting [10]. WMH+ positively correlate with a profile of cytokines involved in resolution of 
inflammation, immunoregulation, and tissue remodeling. Mexico City children with WMH+ 
responded to the air pollution-associated brain volumetric alterations with white and grey matter 
volume increases in temporal, parietal, and frontal regions and better cognitive performance 
compared to MC children with WMH-.  Thus, a complex modulation of cytokines and chemokines 
influences children's brain structural and volumetric responses and cognitive correlates resulting 
from environmental pollution exposures. Most recent investigations are implicating genetic 
factors, in particular, emerging evidence shows APOE genotype may play a pivotal role in the 
cognitive responses of urban children [19].This is very relevant to future increased risk of 
Alzheimer disease development. Indeed, the APOE 4 allele is the most prevalent genetic risk for 
AD [20]. APOE ε4 versus ε3 children had a reduced NAA/Cr ratio in the right frontal white matter 
and decrements on attention, short-term memory, and below-average scores in Verbal and Full 
Scale IQ (>10 points). APOE modulated the group effects between WISC-R and left frontal and 
parietal white matter, and hippocampus metabolites. APOE ε4 carriers could have a higher risk of 
developing early AD if they reside in a polluted environment [19]. Higher concentrations of metals 
associated with PM: manganese (p=0.003), nickel and chromium (p=0.02) along with higher frontal
COX2 mRNA and IL1β and olfactory bulb COX2- indicating neuroinflammation, are present in 
brains of Mexico City children and young adults, thus we also have to consider PM-metal 
neurotoxicity as a key factor likely accounting for brain damage in young urbanites[21]. 
Exposure to heavy metals including the emissions released by ferroalloy plants containing 
manganese and other metals are not uncommon, as shown in Valcamonica, Italy. High 
concentrations in soil and biomarkers associated with deficits in olfactory and motor function are 
the rule in children age 11-14 years [22]. 
In sharp contrast in terms of air pollutants, wood  smoke exposures as measured by carbon 
monoxide yielded inverse associations between CO exposure of pregnant mothers during their 3rd 
trimesters and child neuropsychological performance, including deficits in visuo-spatial integration,
short-term memory recall, long-term memory recall, and fine motor performance [15]. Longitudinal
birth cohort studies on chronic early life pollutant exposures, bring up the issue of the critical 
importance of prenatal exposures and the role of the placental barrier in the final brain effects on the
fetus. Curtis et al., identified glutamate as the active factor release from the placenta/cytotrophoblast
barriers in vitro after hypoxia or hypoxia/reoxygenation, capable of damaging developing neurons 
under experimental conditions [23]. Thus, additional factors to consider would be the placental 
damage by the culprit air pollutant and the resulting release factors damaging the developing brain, 
functionally effective tight junctions present in embryonic brain, specific transport of plasma 
proteins across the blood-CSF barrier and embryo-specific intercellular junctions between 
neuroependymal cells lining the ventricles[24].      
Polycyclic aromatic hydrocarbons (PAHs), the ubiquitous pollutants
PAHs exposures deserve special attention, because they are widely distributed in urban, 
occupational and rural environments and because in spite of their detrimental health and specific 
brain effects, we do not measure PAHs routinely. 
People’s exposures to PAHs -complex mixtures containing over 100 compounds- are associated 
with fine particle bound PAHs, abounding in indoor and outdoor air, household environmental 
tobacco smoke, cooking with biomass, landfill biogases, petrochemical complex emissions, coke 
industry and steel metallurgy soil contamination, commuter life time in freeways and busy 
roadways, diets with smoked or charbroiled meat and meat products, frying oils and snacks, and 
occupational exposures. Marseille is a prime example of an urban port center with > 1 million 
residents who — along residents in New York, Boston, Phoenix, Montreal, Los Angeles and 
Mexico City— are exposed to high concentrations of total PAHs (Figure 1A) and benzo [a]pyrene 
(Figure 1B).This stands in stark contrast to lower exposures in rural and suburban areas, i.e., 
Chesterfield, SC, population 5650, 30 people per km2 and Deer Park, TX, 3560 people per km2.  
The situation is worse in developing countries, where increases in migrant populations, poor 
atmospheric PAHs reduction measures from traffic and industry, and dependence on biofuel 
contribute to high levels of PAH and PM 2.5 as is the case of Metropolitan Mexico City where 24 
million residents are greatly exposed on daily bases (Figures 1A, 1B). 
Figure 1.   (A) Sum of the average concentrations of 12 PAHs, and, (B) the average concentrations 
of Benzo(a)pyrene in PM in several areas of North America and South of France.
 The sum of the PAHs include: phenanthrene, benzo(a)pyrene, benzo(b)fluoranthene, 
benzo(a)anthracene, fluorene, fluoranthene, pyrene, chrysene, benzo(k)fluoranthene, 
dibenzo(a,h)anthracene, indene(1,2,3-cd)pyrene, and Benzo(ghi)perylene. Data of PAHs are for 
the years: 2012 Canada sites; 2010 U.S.A. sites, 2005-2007 Mexico City sites, and July, 2004 South 
of France. 
Prenatal PAHs exposures are harmful to the developing brain, high levels of PAH-DNA 
adducts in cord blood have been associated with neural tube defects, and occupational exposures 
during pregnancy increase the risk for small for gestational age babies [25-27]. In the U.S. 
exposures to PAHs as measured by urine metabolites, are seen across all ages with particularly 
high concentrations in 6 to 11 year olds [28]. Heating oil combustion and indoor sources of pyrene 
are key contributors to PAHs in cities like New York [29].  PAHs exposures are also associated with 
higher body mass index (BMI), waist circumference and obesity in 6-11 year old U.S. children [30]. 
Readers also have to be aware that high levels of poverty, low educational attainment, and below 
average mother’s IQ are critical confounder factors to evaluate cognition in children exposed to air
pollutants [25]. 
32. Neuroinflammatory and neurodegenerative changes 
In the common scenario of air pollution exposures, i.e., the urban resident living close to a busy 
road, exposed to complex mixtures in his way to work, driving his car, taking the bus or the 
subway, with a work place with other sources of toxics, goes back to his home where cooking is 
taking place, has a cigarette before going to bed, puts the heat on or opens the windows for 
ventilation, etc., inflammation is the key pathway linking complex pollutant exposures and CNS 
damage. 
The initial inflammatory process involves the upper and lower respiratory tract, follow by spilling 
of the process to a systemic inflammatory response and the production of inflammatory mediators 
capable of reaching the brain. If our lady urbanite is pregnant, then air pollutant components can 
cross the placental barrier, directly affecting the embryo and the fetus [23, 24]. Continuous 
expression of potent inflammatory mediators in the CNS and the formation of reactive oxygen 
species (ROS) are major findings in urban residents. Ultrafine PM (UFPM), PM-LPS, and metal 
uptake take place through olfactory neurons, cranial nerves such as the trigeminal and vagus, the GI
tract, the systemic circulation, and macrophage-like cells loaded with PM from the lungs[31-36]. 
Swallowing of tiny particles for example, allows for the direct contact of particulate components 
with the fragile small bowel mucosa, disrupting the tight junctions and breaking the integrity of the 
gastrointestinal (GI) barrier [36]. Activation of the brain innate immune responses resulting from 
the interaction between circulating cytokines and constitutively expressed cytokine receptors 
located in brain endothelial cells is followed by activation of cells involved in adaptive 
immunity[37]. Interactions between microglia, mast cells, endothelial cells, and macrophages are 
critical in inflammation and impact behavior [38, 39].  
Systemic oxidative stress and brisk inflammatory responses are seen in animal models and in 
humans exposed to polluted environments with diverse PM chemistry, including residual oil flash, 
endotoxins, and metals as well as high concentrations of criteria pollutants[40-42]. The individual 
inflammatory responses to air pollutants depend of diverse factors, including mitochondrial genetic 
background, age, gender, and chronic diseases [43, 44].  
A key component of air pollution exposure is neuroinflammation [45]. In megacity children there is 
a significant frontal lobe imbalance in genes essential for inflammation, innate and adaptive 
immune responses, oxidative stress, cell proliferation and apoptosis [33]. The up-regulation of 
potent inflammatory mediators involves supra and infratentorial regions and cranial nerves 
including: olfactory bulb, frontal cortex, substantia nigrae and the vagus [35].  
Chronic inflammatory perivascular infiltrates and activated microglia in the frontal and temporal 
cortex, subicular area, and the brainstem are commonly present in MCMA children, while they are 
rare in controls. There is also evidence of highly oxidized and covalently cross-linked aggregates of 
proteins affecting endothelial cells in brain capillaries i.e., the presence of abundant lipofuscin [35]. 
This finding is good evidence of a dysfunctional lysosomal degradation, not expected in children or 
young adults.
Based on the current literature, we know that air pollution PM and environmental nanoparticles are 
risk factors for the development of neuroinflammation and neurodegeneration[46-51]. Ultrafine 
particles (UFPs) are the most abundant particulate pollutants in urban and industrial areas, and their 
exposures have increased significantly because of anthropogenic sources including internal 
combustion engines, power plants, incinerators and many other sources of thermo-degradation. 
UFPs are able to stimulate inflammatory responses, damaging epithelial cells, breaking barriers and 
gaining access to the interstitium[46]. There are a significant number of proteins adsorbed onto 20 
nm sized SiO2 nanoparticles than onto the 100 nm sized nanoparticles regardless of charge. 
Proteins bound on the surface of nanoparticles may affect functional and conformational properties 
and distributions in complicated biological brain processes[51]. Exposure to different size and 
composition PM is associated with production and deposit of misfolded protein aggregates 
(amyloid, alpha synuclein, hyperphosphorilated tau), oxidative stress, cell damage and death in 
susceptible neuronal populations [52-54]. 
 The  early  neural  events  including  extensive  oxidative  stress  [55],  observed  in  our  exposed
populations are key for pathways conducing to neurodegeneration, since recent works emphasize
AD pathology as “an active host response or an environmental adaptation” [56].  
The  presence  of  neuroinflammation  as  evidenced  by  up-regulation  of  gene  network  clusters
interleukin-1 (IL-1), nuclear factor kappa B (NFκB), interferon (IFN) and toll-like receptors (TLRs)
along with tau hyperphosphorilation in MCMA children and young adults compared to controls,
supports  the  role  of  air  pollution  in  their  brain  responses  [33].  A  15-fold  frontal  lobe  down-
regulation  of  the  prion-related  protein  (PrP(C))  was  a  striking  finding  in  MCMA  young
urbanites[33].  The  down-regulation  of  the  PrP(C)  is  critical  given  its  important  roles  for
neuroprotection, neurodegeneration, and mood disorder states. 
33. Breakdown of epithelial and endothelial barriers: no barrier is intact.
All barriers are damaged by air pollutants.  A common target and a portal of entry are the nasal 
passages. A key feature of a chronically inflamed nasal and paranasal epithelia is that inflammatory 
mediators are released to the systemic circulation[57], and thus, their contribution to systemic 
inflammation and dysregulation are important.  The issue acquires a great importance in the context 
of air pollution because olfactory dysfunction is among the earliest features of AD and Parkinson’s 
disease (PD), occurring in ~ 90% of early onset cases [58]. Early olfactory deficits in MCMA 
young residents appear to be associated with the presence of β amyloid, α synuclein, ultrafine PM 
(<100 nm) in glomerular structures and massive distortion of the olfactory bulb organization[34]. 
While the breakdown of the nasal, olfactory, BBB, and alveolar-capillary barriers has
been extensively  documented,  the  research on the  involvement  of  the  gastrointestinal
barrier is at the earliest stages. There is evidence the GI tract barrier is also compromised
in the air pollution setting and recent research links inflammatory bowel diseases, changes
in  gut  microbiome,  and  abdominal  pain  with  air  pollution  [59-62].  The  integrity  of  the
gastrointestinal  (GI)  barrier  is  compromised  in  MC dogs  and  could  be  altered  in  MC
children as evidenced by the autoimmune response to TJ and neural proteins [31, 36]. 
The GI breakdown likely impacts neuronal enteric populations and PM could reach the
vagus and the brainstem. In the setting of urban air pollution, the evolution of a changing
paradigm  favoring  a  pathogen  penetrating  an  epithelial  lining  and  via  transsynaptic
transmission  reaching  preganglionic  parasympathetic  motor  neurons  of  the  vagus
nerve[63]  has  to  entertain  environmental  swallowed  particulate  matter  as  a  potential
culprit. We suggested that damage to epithelial and endothelial barriers associated to air
pollution exposures is a robust trigger of tight junction and neural antibodies [31]. Cryptic
'self' tight junction antigens can trigger an autoimmune response potentially contributing to
the  neuroinflammatory  and  Alzheimer  and  Parkinson’s  pathology  present  in  megacity
children. A key piece of information is that a major factor determining the impact of neural
autoantibodies  is  the  integrity  of  the  blood-brain  barrier[64,  65].   Thus  immunological
dysregulation  and  the  critical  “double-edged  sword”  [56]  of  a  fine  balance  between
protective and detrimental effects as a response to air pollution in a developing brain is a
major issue in young urbanites [37].
34. Brainstem pathology
Brainstem neuroinflammatory and degenerative changes are key in exposed children and young
adults. Misfolded α-synuclein is present in 23.5% of < 25 y MC residents [66] and the  brainstem
distribution  of  this  protein  follows  key  anatomical  regions  known  to  be  involved  early  in
Parkinson’s disease (PD) stages [67, 68]. Specifically, α-synuclein has been observed in the dorsal
vagal   nucleus,  solitary  complex,  lower  raphe  nuclei,  locus  coeruleus  and  pedunculo-pontine
nuclei, as well as in the olfactory bulb of young MC residents [34, 66]. These findings correspond
to Braak stages I and II of PD characterized by autonomic and olfactory disturbances[67-69], that
are indeed present in our exposed pediatric cohorts [66]. Our observations put forward a key
question raised by numerous researchers: What events trigger the onset of Parkinson’s disease?
One important question begging an answer because by the time PD motor symptoms are present,
the pathology is irreversible[70]. 
If we follow Braak’s PD neuropathology staging, the earlier pathological changes (stages I and II)
are observed in the olfactory bulb and brainstem; the motor symptoms relate to stage III  and
beyond.  Further,  autonomic  disturbances  are  early,  as  many  as  4  decades  before  motor
manifestations. It  would be extremely difficult to ignore landmark papers pointing towards the
relationship  between  the  intranasal  neurotoxicant  and  biologically  plausible  pathways  in
explaining involvement of key early PD targets, namely the mucosal barrier of the gastrointestinal
tract  and,  via  postganglionic  enteric  neurons,  entering  the  central  nervous  system  along
unmyelinated praganglionic fibers generated from the visceromotor projection cells of the vagus
nerve” [63], and the olfactory vector hypothesis[71]. We propose these potential pathways are
involved in highly exposed urban children and more importantly, that they lead to involvement of
the brainstem. 
4. Alzheimer’s and Parkinson’s diseases and air pollution
The  interpretation  of  the  early  oxidative  stress,  the  upregulation  of  key  gene  pathways,
neuroinflammation, misfolded proteins in key anatomical areas, etc., in the brains of children and
young  adults  with  lifetime  high  exposures  to  air  pollutants  is  critical  to  the  origin  of
neurodegeneration  in  AD  and  PD.   As  Castellani  and  Perry[56]   point  it  out,  the  prevailing
paradigm of neurodegenerative changes being the etiology rather than a response to detrimental
environments at different levels, no longer holds. We are showing early AD and PD hallmarks in
MCMA children and our findings are not isolated given that other authors are showing that the
development  of  abnormal  tau  for  example,  starts  in  childhood  [72,  73].  Critical  to  our  human
studies,  systemic  inflammation,  neuroinflammation  and  misfolded  protein  aggregates  are
progressive features elicited upon the administration of air pollutant components to experimental
animals[52-54, 74-76].  Our interpretation of AD and PD hallmarks in the setting of air pollution is
on the side of initial  protective responses [32, 33]. In the Alzheimer’s brain,  tau is abnormally
hyperphosphorylated (HP) [77]. 
Tau phosphorylation could be protective (e.g., hibernation) or toxic (e.g., hyperphosphorylation and
aggregation of tau)[78]. Although the aggregation of HP tau species has been proposed to represent
a  compensatory  neuronal  response  against  oxidative  stress  and  to  serve  at  least  initially  as  a
protector  against  cell  death[79,  80],  the  detrimental  effects  of  abnormal  tau  in  AD,  related
tautopathies and under experimental conditions are not subject to controversy [55, 78, 81-84]. 
Jung et al., work establishes the strong association between long-term exposure to O3 and PM2.5 
above the current US EPA standards and increased Alzheimer’s disease risk in a cohort of 
individual>65y. They found a 138% risk of increase of AD per increase of 4.34 μg/m3 in PM2.5 
over the 10y follow-up period [85]. Jung’s work is very relevant to our work and brings the issue of
Alzheimer’s disease development over several decades and thus is subject to neuroprotective 
interventions.
If cellular defense mechanisms try to intervene but fail, as strongly suggested by several authors 
[86], and gene studies point towards the strong association with networks characterized by the very 
same common denominators i.e., oxidative stress,  seen in common diseases that are causing high 
morbility and mortality (cancer, diabetes, renal diseases, and cardiovascular diseases), then why not
pursue the notion that gene changes and the pathology in urban children is indicative of an active 
host response or environmental adaptation as suggested by Castellani and Perry [56].
Alpha-synuclein aggregation is associated to the pathogenesis of Parkinson's disease and exposure
to a myriad of environmental agents, including agrochemicals increases PD risk[87, 88]. That being
said, we need to emphasize that α-synuclein in MC children is present in key regions associated
with PD pathology:  olfactory bulb,  midbrain  and the lower sections  of  the brainstem,  e.g.,  the
medulla  oblongata.  Moreover,  MC teens  exhibit  already  olfactory  disturbances  and  autonomic
dysfunction (i.e., syncope) severe enough to require pediatric care. 
The  presence  of  up-regulated  inflammatory  cytokines,  α-synuclein  and  HPπ  olfactory  bulb
pathology in MCMA children along the breakdown of the GI duodenal barrier  in Mexico City
young  dogs  and  autoantibodies  against  tight  junction  proteins,  are  ominous  signs  possibly
associated with a number of other non-motor symptoms related to PD, such as dysautonomia and
sleep disturbances[89, 90]. 
The key role of APOE 4
The results of the clinical and neuropathological studies in highly exposed children strongly 
suggests that carriers of the allele ε4 of apolipoprotein E4 (APOE ε4), the most prevalent genetic 
risk factor for sporadic AD (21), have significantly more cognitive and neuropathology changes that
APOE ε3 carriers.  
If indeed there is interest in preventing AD, if we know that urban children with an APOE ε4 are 
clearly showing cognitive deficits, greater hyperphosphorylated tau and diffuse Aβ plaques versus 
E3 carriers (Q = 7.82, p = 0.005) [37] why not to target apoE4 and pave the way for future studies? 
Pediatric research linking Alzheimer’s early hallmarks with air pollution has been totally ignored by
the grant supporting institutions. 
5. The need for neuroprotection in high-risk children and young adults
Early neuroprotection of high-risk urban children and young adults should be in the agenda of 
health federal agencies. The inducible regulation of key gene pathways in young brains suggests 
they are evolving different mechanisms in an attempt to cope with the constant state of 
inflammation and oxidative stress related to their environmental exposures[33]. Cellular defense 
mechanisms try to intervene but fail, finally resulting in AD pathology as the disease 
progresses[91]. Oxidative stress is at the core of Alzheimer's disease and genomic vulnerability [92]
is important in the scenario of air pollution.
6. Environmental risk factors in MS
Many factors, including both genetic and environmental, have been suspected of being associated 
with MS. A complex interaction between environmental factors with susceptibility genes probably 
leads to the onset of the disease. The most likely environmental factors are sunlight exposure 
mediating vitamin D synthesis and UV radiation [93]. EBV stands out as an infectious agent that 
can explain many features of MS epidemiology[94]. Several lines of evidence also suggest smoking 
as a modifiable risk factor for MS [95-97].
6.1. Air pollution as a risk factor in MS
UV and vitamin D have been implied as most prominent environmental factors describing the 
latitudinal gradient of MS prevalence observed among European descent nations [98]. There is an 
inverse relationship between serum vitamin D level and MS clinical activity [99]. High circulating 
levels of vitamin D are associated with a lower risk of multiple sclerosis [100, 101]. Exposure to 
sunlight is the main source of vitamin D requirement for many people and may also exert a 
protective effect in MS patients. 
Air pollutants could also contribute to low circulating vitamin D levels of inhabitants of polluted 
areas. Women and children in areas with high levels of air pollutants had significantly lower 
vitamin D level [102, 103]. Increased maternal exposure to NO2 and PM10 during the whole 
pregnancy might be associated to lower cord blood serum 25(OH) D levels at birth [104], 
furthermore the high tropospheric ozone content of urban areas is also a risk factor for vitamin D 
deficiency [105]. 
Adverse effects of air pollutants on central nervous system has been observed in post-mortem 
studies of inhabitants of polluted cities [106]. In a later study, neuroinflammation, altered blood 
brain barrier, and particulate deposition in the brain of children and young adults living in cities 
with high air pollution was observed [35]. Only few studies have considered possible role of air 
pollutants in pathogenesis of MS or of MS relapses. They are described below.
A retrospective study in south-western Finland, including 1205 relapses which occurred among 
406 patients in 14-year period 1985-1999, has shown a strong relationship between MS relapses 
and peak amounts in PM10 and  SO2+NO2+NO levels [107]. Odds ratio were respectively 3.0 [1.2-
7.7] and 11.7 [3.3-42.0] without lag, and 4.1 [1.6-10.6] and 9.3 [2.7-31.4] with one month lag. This 
study was conducted on a long period and included a large number of events that were 
systematically authenticated by a neurologist. However, no information regarding DMTs or clinical 
characteristics of the disease was considered, and the methods to measure air pollutants were not
described. Therefore, the exposure measurements may be not so accurate.
The best model predicting clustered pattern of female MS patients in Georgia
included PM10 [108]. This American study has studied MS prevalence at county
level in Georgia using an ecological design. Significant associations were found
between MS prevalence and PM10 levels, as well as MS prevalence and income
levels.  Study  population  comprised  9 072 576  people,  of  whom 6 247 were
declared as MS to the regional section of « Multiple Sclerosis Society ».  This
study, despite its large size, has several methodological weaknesses, such as
self-declared  diagnosis  of  MS  (not  validated  by  neurologists),  lack  of  age-
adjusted  prevalence  estimates,  and  imprecise  measure  of  air  pollutants
(county level  which is  big).  Moreover,  there may be a potential  bias in the
chronological  sequence  between  exposure  measured  in  1999  and  MS
prevalence measured in 2005. 
 Indeed, MS cases who started before 1999 are included while they have not
been exposed  to  the  studied  exposure,  unless  pollution  levels  in  1999  are
supposed to be equivalent to previous levels.
Clustering pattern of MS prevalence patients were also observed in Tehran [109, 110], and a 
significant difference in long term exposure to PM10, SO2, NO2, and NOx was observed in MS cases 
compared with controls [109]. A recent study in Tehran found higher relapse rate during the winter 
and following first month of the spring and MS relapses were correlated with NO levels [111]. They
also found that most air pollutants such as NO2, NO and CO are in high levels in the rainy season. 
Others like Pm10 and Nox are in high levels in the dry season. The correlation between NO2 levels 
of all markers of air quality and MS relapses (P=0.03, r=0.27) was weak. Best ARIMA model was 
determined between number of monthly relapses and living place, although this model was not 
significant (P=0.3). 
In Serbia, the results confirmed the influence of air pollution and climate seasonal conditions on 
disease relapses in MS patients based on a long-term observation (5 years). Lower numbers of 
days with low air pollution during the periods with low vitamin D (January–April), especially with 
increased cloudiness at 2 p.m, induce a higher risk of MS relapses in southern continental parts of 
Europe [112] . In this study, period under DMTs were excluded, and the diagnosis of relapses were
always established by MS specialized neurologists. Methods to measure exposure are clearly 
exposed. Oikonen et al suggested that PM10 increased susceptibility to adenoviral infections, 
hence increasing the relapse rate in MS patients [113]. 
A French study regarding the potential association between air pollutants and MS relapses is ongoing in 
Strasbourg city in North Eastern France. A total of 254 patients accounting for 1143 relapses in the period 
2000-2009 have been included. A case crossover design has been selected, i.e. the analysis will be 
performed by comparing among each patient the air pollutants levels observed in period where relapses 
occurred with period without relapses. 
This design allows controlling for individual confusion factors such as gender, age at MS onset etc. 
Preliminary results (unpublished yet) showed a significant association between PM10 levels during the 3 
previous days and the risk of relapse (OR=1.3; 95%CI 1.1-1.7)
Seasonal  variation  of  MS  relapses  was  also  confirmed  in  a  recent  meta-
analysis. Their frequency is higher in spring and lower in winter, which is in
favor of seasonal risk factors for MS, such as air pollutants.  
6.2. Air pollutants play a role in neuroinflammation
Evidence from lab studies suggest that ultrafine particulate matter affects CNS inflammatory 
processes and increase biomarkers of inflammation in mouse brain [114, 115]. Levels of pro-
inflammatory cytokines (IL-1α, TNF-α) and the immune related transcription factor (NF-kB) were 
increased in brain tissue of mice exposed to particulate matter compared to that of control 
animals [114]. Mice exposed to two levels of concentrated ultrafine particulate matter in central 
Los Angeles showed aberrant immune activation in the brains as judged by a dose-related increase
in nuclear translocation of two key inflammatory transcription factors (NF-κB and AP-1)[115]. In 
another study, baseline levels of the pro-inflammatory cytokines (TNF-α, IL-1α) were increased in 
the striatum after exposure to diesel engine exhaust. A similar, though not significant, trend was 
seen with the mRNA expression levels of TNF-α and TNF Receptor-subtype I [116].
63. Future directions 
Variations in exposure to air pollutants during disease course should be quantified in longitudinal 
studies with detailed assessment batteries on various clinical aspects of MS to allow researchers 
reveal potential role of air pollutants in MS pathogenesis. Appropriate study designs have to be 
selected in order to control to most of confounding and reach a high level of evidence. Moreover, 
epigenetic studies may be of interest in order to highlight the mechanisms responsible for the role 
of air pollutants in pathogenesis of MS or MS relapses.
7. Conclusions
Air  pollution  has  become  a  key  issue  in  Public  Health  (at  a  local  and  regional  level)  and  in
Environmental  Sciences.  What  can  we  do?  Improving  air  quality  and  identifying  the  young
urbanites with the most risk for neurodegeneration are key to protect our residents. But solutions
will have to come from Policy and politics.
Early cognitive deficits are associated with prenatal and early postnatal air pollutant exposures, 
brain structural, volumetric and metabolic changes are described in adolescence and early adulthood
with significant cognitive deficits that will negatively impact the academic, labour and social 
performance of the affected individuals. Pursuing the notion that gene pathway changes and the 
neuropathology in urban children and young adults is indicative of an active host response or 
environmental adaptation [56] and that genetic factors play a key role (APOE ε4) (21) why not 
target the obvious and pave the way for future studies? 
It is interesting to consider the evolution of the awareness of this issue. Disasters related to acute air 
pollution hit Europe and the US in the twenty-century. They led to a great societal and political concern
and to regulatory actions (Clean Air Act in 1956 UK and in 1970 in the US) [2], extending progressively 
into the word (e.g. European Clean Air Package)[117]. By the end of the twenty-century, air quality 
improves in western countries: lower pollutants concentration, mostly chronic or sub-acute exposure. 
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